These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 17415644)

  • 1. Chronic hypergastrinemia: causes and consequences.
    Orlando LA; Lenard L; Orlando RC
    Dig Dis Sci; 2007 Oct; 52(10):2482-9. PubMed ID: 17415644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis and treatment of gastrinoma in the era of proton pump inhibitors.
    Banasch M; Schmitz F
    Wien Klin Wochenschr; 2007; 119(19-20):573-8. PubMed ID: 17985090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and differential diagnosis of hypergastrinemia.
    Arnold R
    Wien Klin Wochenschr; 2007; 119(19-20):564-9. PubMed ID: 17985088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consequences of long-term proton pump blockade: insights from studies of patients with gastrinomas.
    Jensen RT
    Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):4-19. PubMed ID: 16433886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypergastrinemia--diagnosis and treatment.
    Niederle B
    Wien Klin Wochenschr; 2007; 119(19-20):561-3. PubMed ID: 17985087
    [No Abstract]   [Full Text] [Related]  

  • 6. Pathobiology and management of hypergastrinemia and the Zollinger-Ellison syndrome.
    Hirschowitz BI
    Yale J Biol Med; 1992; 65(6):659-76; discussion 689-92. PubMed ID: 1341070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discussion on the effect of chronic hypergastrinemia on human enterochromaffin-like cells: insights from patients with sporadic gastrinomas.
    Cattan D
    Gastroenterology; 2003 Aug; 125(2):627; author reply 627-8. PubMed ID: 12891576
    [No Abstract]   [Full Text] [Related]  

  • 8. Assessing for Multiple Endocrine Neoplasia Type 1 in Patients Evaluated for Zollinger-Ellison Syndrome-Clues to a Safer Diagnostic Process.
    Singh Ospina N; Donegan D; Rodriguez-Gutierrez R; Al-Hilli Z; Young WF
    Am J Med; 2017 May; 130(5):603-605. PubMed ID: 28011308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inter-relationship between serum gastrin levels, gastric mucosal histology and gastric endocrine cell growth.
    Creutzfeldt W; Lamberts R
    Digestion; 1992; 51 Suppl 1():76-81. PubMed ID: 1397748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histomorphological characteristics of gastric mucosa in patients with Zollinger-Ellison syndrome or autoimmune gastric atrophy: role of gastrin and atrophying gastritis.
    Lehy T; Roucayrol AM; Mignon M
    Microsc Res Tech; 2000 Mar; 48(6):327-38. PubMed ID: 10738314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypergastrinemia and gastric enterochromaffin-like cells.
    Bordi C; D'Adda T; Azzoni C; Pilato FP; Caruana P
    Am J Surg Pathol; 1995; 19 Suppl 1():S8-19. PubMed ID: 7762739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights into Effects/Risks of Chronic Hypergastrinemia and Lifelong PPI Treatment in Man Based on Studies of Patients with Zollinger-Ellison Syndrome.
    Lee L; Ramos-Alvarez I; Ito T; Jensen RT
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31623145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression of gastric enterochromaffin-like cells growth in Zollinger-Ellison syndrome and atrophic body gastritis patients.
    Delle Fave G; Marignani M; Corleto VD; Angeletti S; D'Ambra G; Ferraro G; D'Adda T; Azzoni C; Jensen RT; Annibale B; Bordi C
    Dig Liver Dis; 2002 Apr; 34(4):270-8. PubMed ID: 12038811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis of Zollinger-Ellison syndrome: increasingly difficult.
    Ito T; Cadiot G; Jensen RT
    World J Gastroenterol; 2012 Oct; 18(39):5495-503. PubMed ID: 23112541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zollinger-Ellison syndrome in a patient with normal screening gastrin level.
    Yanda RJ; Ostroff JW; Ashbaugh CD; Guis MS; Goldberg HI
    Dig Dis Sci; 1989 Dec; 34(12):1929-32. PubMed ID: 2598759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical value of determining pepsinogen I].
    Griessen M; Male PJ; Infante F; Jodry H; Loizeau E
    Schweiz Med Wochenschr; 1984 Dec; 114(49):1849-51. PubMed ID: 6515384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Old and New Gut Hormone, Gastrin and Acid Suppressive Therapy.
    Haruma K; Kamada T; Manabe N; Suehiro M; Kawamoto H; Shiotani A
    Digestion; 2018; 97(4):340-344. PubMed ID: 29587283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of chronic hypergastrinemia on human enterochromaffin-like cells: insights from patients with sporadic gastrinomas.
    Peghini PL; Annibale B; Azzoni C; Milione M; Corleto VD; Gibril F; Venzon DJ; Delle Fave G; Bordi C; Jensen RT
    Gastroenterology; 2002 Jul; 123(1):68-85. PubMed ID: 12105835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antisecretory drugs, hypergastrinemia and hyperplasia of enterochromaffin-like cells (ECL)].
    Andriulli A; Mangia A; Lawson F
    Minerva Gastroenterol Dietol; 1991; 37(3):135-40. PubMed ID: 1686409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypergastrinemia as a cause of chromogranin a increase in blood in patients suspected to have neuroendocrine tumor.
    Kleveland O; Syversen U; Slørdahl K; Waldum HL
    Digestion; 2001; 64(2):71-4. PubMed ID: 11684818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.